These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4974812)

  • 1. [Interpretation of the clinical signs in the light of recent acquisitions].
    Heyck H
    Minerva Med; 1968 Dec; 59(96):5200-6. PubMed ID: 4974812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electroencephalographic findings in the course of cerebrovascular diseases in aged subjects and their changes under the influence of sympathicolytic therapy (hydergine)].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    G Gerontol; 1966 Dec; 14(12):1221-5. PubMed ID: 4966653
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of sympatholytics (hydergine) in association with other drugs in the prevention and treatment of post-operative acute renal insufficiency].
    Morra A; Pettinelli U
    Minerva Chir; 1970 Dec; 25(23):1600-6. PubMed ID: 4994489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral vasodilator therapy in stroke.
    McHenry LC
    Stroke; 1972; 3(6):686-91. PubMed ID: 4629450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sympatholytic vasodilator in cerebral circulation disorders].
    Lipke PR
    Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension in patients with cerebrovascular insufficiency].
    Strazzullo P; Ferrara LA; Lamenza F; Tudisca G; De Cristofaro M
    Acta Neurol Quad (Napoli); 1980; 41():82-5. PubMed ID: 7293742
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 12. [On treatment of acute cerebrovascular accidents].
    Berselli L; Ferracini R
    Clinica; 1965 Sep; 25(1):68-75. PubMed ID: 4954699
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electroencephalographic and clinical study of the action of hydrogen derivatives of Ergotoxin].
    Borenstein P; Cujo P; Bahon L
    Ann Med Psychol (Paris); 1969 Oct; 2(3):410-24. PubMed ID: 4983442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of hydergine on cerebrovascular insufficiencies in hypertensive patients].
    Pacheco e Silva A
    Hospital (Rio J); 1970 Jul; 78(1):49-53. PubMed ID: 4991828
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic cerebrovascular insufficiency in the elderly. Perspectives on treatment.
    Rosen HJ
    J Med Soc N J; 1972 May; 69(5):445-8. PubMed ID: 4623096
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the behavior of cerebrovascular resistance under the influence of sympatholytics].
    Klein K; Siedek H
    Wien Med Wochenschr; 1966 Jan; 116(1):20-2. PubMed ID: 4962461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 19. [The place of a peripheral vasodilator agent in the treatment of shock states].
    Lareng L; Jorda MF; Cathala B; Mathelin D
    Anesth Analg (Paris); 1974; 31(1):41-51. PubMed ID: 4210208
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
    Kaye C
    Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.